Growth Metrics

Envoy Medical (COCH) Amortization of Deferred Charges (2024 - 2025)

Envoy Medical recorded quarterly Amortization of Deferred Charges of $4000.0 in Q4 2025, down 99.15% quarter-over-quarter from $468000.0 in Q3 2025, and down 98.96% year-over-year from $384000.0 in Q4 2024.

Envoy Medical's Amortization of Deferred Charges history runs 2 years deep, the most recent figure standing at $4000.0 for Q4 2025.

  • In Q4 2025, Amortization of Deferred Charges fell 98.96% year-over-year to $4000.0; the TTM figure through Dec 2025 stood at $1.6 million (changed N/A YoY), while the FY2025 annual figure was $1.6 million, up 94.85% from the prior year.
  • Amortization of Deferred Charges came in at $4000.0 for Q4 2025 at Envoy Medical, down from $468000.0 in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $623000.0 in Q2 2025 to a low of $4000.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Envoy Medical 48.11 Mn 22.86 Mn -274,000.00

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 4,000.00
Dec 31, 2025 4,000.00
Sep 30, 2025 468,000.00
Sep 30, 2025 468,000.00
Jun 30, 2025 623,000.00
Jun 30, 2025 623,000.00
Mar 31, 2025 495,000.00
Mar 31, 2025 495,000.00
Dec 31, 2024 384,000.00
Dec 31, 2024 384,000.00
Sep 30, 2024 264,000.00
Sep 30, 2024 264,000.00